US Orphan Drug Pipeline Analysis

Publish Date:- Oct-2013   No Of Pages (880 )

Electronic Access - Single User License $ 1800 Buy Now

CD-ROM Mail Delivery $ 2400 Buy Now

Hard Copy Mail Delivery $ 3000 Buy Now

Electronic Access - Multi-User License $ 3600 Buy Now


    1. US Orphan Drug Market Overview

     

    2. US Orphan Drug Market Regulatory Framework

      2.1 General Provisions

      2.2 Written Recommendations for Investigations of Orphan Drugs

      2.3 Designation of an Orphan Drug

      2.4 Orphan Drug Exclusive Approval

      2.5 Open Protocols for Investigations

      2.6 Availability of Information

     

    3. Orphan Drug Clinical Phase: Research

      3.1 Overview

      3.2 Orphan Drug Profiles in Clinical Phase

     

    4. Orphan Drug Clinical Phase: Preclinical

      4.1 Overview

      4.2 Orphan Drug Profiles in Clinical Phase

     

    5. Orphan Drug Clinical Phase: Phase-I

      5.1 Overview

      5.2 Orphan Drug Profiles in Clinical Phase

     

    6. Orphan Drug Clinical Phase: Phase-I/II

      6.1 Overview

      6.2 Orphan Drug Profiles in Clinical Phase

     

    7. Orphan Drug Clinical Phase: Phase-II

      7.1 Overview

      7.2 Orphan Drug Profiles in Clinical Phase

     

    8. Orphan Drug Clinical Phase: Phase-II/III

      8.1 Overview

      8.2 Orphan Drug Profiles in Clinical Phase

     

    9. Orphan Drug Clinical Phase: Phase-III

      9.1 Overview

      9.2 Orphan Drug Profiles in Clinical Phase

     

    10. Orphan Drug Clinical Phase: Pre-Registration

      10.1 Overview

      10.2 Orphan Drug Profiles in Clinical Phase

     

    11. Orphan Drug Clinical Phase: Registered

      11.1 Overview

      11.2 Orphan Drug Profiles in Clinical Phase

     

    12. Marketed Orphan Drugs

    12.1 Overview

    12.2 Orphan Drug Profiles

    Each Drug Profile has Tables Representing Following Information:

    • Alternate Names

    • Originator & Owner

    • Collaborator

    • Technology Provider

    • Licensee

    • Highest Development Phase

    • Indications

    • Class

    • Mechanism of Action

    • ATC code

    • Designated Brand Name & Orphan Designation

  • Report Title:
    Name:
    Email address:
    Job title:
    Organisation:
    Contact number:
    Postal/Zip code:
    Country:
    Comments:
Copyright © 2013 PNS Pharma. All Right Reserved.